Canon BioMedical Launches First Commercial Products For Life Science Researchers
Novallele™ Genotyping Assays and Mastermix enable the rapid detection of variations in the human genome
MELVILLE, N.Y., September 9, 2015 - Canon BioMedical, Inc., a wholly owned subsidiary of Canon U.S.A., Inc., today announced the launch of the Novallele genotyping assay library and chemistry, the Company's first commercial products. The Novallele Genotyping Assays enable genetic researchers to identify single nucleotide polymorphisms (SNP) and small insertions and deletions in the human genome.
"Canon BioMedical is excited to be releasing our first commercial products to support genetic research," said Akiko Tanaka, president and CEO, Canon BioMedical, Inc. "Canon BioMedical has partnered with academic centers, commercial organizations and other Canon companies to deliver these new solutions to the life science research market. These are our first steps in delivering a suite of tools designed to help empower the widespread adoption of personalized medicine."
The Novallele genotyping assays are designed for rapid polymerase chain reaction (PCR) followed by high-resolution melting analysis (HRMA). The Novallele Mastermix is a companion chemistry optimized for use with the assays on any HRMA-compatible thermocycler.
Canon BioMedical will be presenting the products at the American Society of Human Genetics Annual Meeting on Oct. 9, 2015 in Baltimore, Maryland. To support the release of these products, Canon BioMedical has launched its website, www.canon-biomedical.com.
About Canon BioMedical, Inc.
Canon BioMedical, Inc. is focused on empowering the biomedical research and healthcare communities by developing, manufacturing and marketing innovative technologies and solutions. The technologies and solutions developed will help enable clinicians and scientists to improve our health and advance science. Canon BioMedical will continue to pursue innovative solutions in line with Canon's Kyosei philosophy of social and environmental responsibility through the use of existing and emerging Canon technology, as well as strategic partnerships.
Products mentioned in this release are for Research Use Only. Not for use in diagnostic procedures.
All referenced product names, and other marks, are trademarks of their respective owners.
Novallele Genotyping Assays